A study published in JAMA Network Open observed a shift in the incidence of second primary cancers after metastatic melanoma that specifically changed during the age of immune checkpoint inhibitors (ICIs) and most commonly manifesting as cancers of the small intestine and myeloma.
Scientific Publications
Avastin Plus Chemotherapy Improves Progression-Free and Overall Survival in Mucosal Melanoma
Avastin (bevacizumab) with carboplatin plus paclitaxel improved overall survival (OS) and progression-free survival (PFS) compared with carboplatin and paclitaxel alone in patients with metastatic mucosal melanoma, according to findings from a phase 2 study published in the Journal of Clinical Oncology.
Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice
Researchers conducted this retrospective multicentre cohort study with the aim to determine clinicopathological characteristics, treatment patterns, clinical outcomes and prognostic factors in patients with vulvar melanoma (VM).
Survey estimates one fifth of melanomas undiagnosed during Covid-19 pandemic
A recent survey of over 700 dermatologists around the world has revealed the shocking impact of the Coronavirus pandemic on the detection of melanoma skin cancer.